In the wake of acute shortage of anti-rabies vaccine (ARV), Chief Minister Arvind Kejriwal on Wednesday approved the Health Department's proposal for its emergency procurement.
"The Delhi Cabinet, in its meeting on Wednesday, chaired by Chief Minister Arvind Kejriwal approved the Health Department's proposal for emergency procurement of ARV, and also granted its ex-post facto approval for the already purchased ARV by the Department," stated a press release.
With this order, the Cabinet approved the procurement of 80,000 vials of the ARV on a single bid basis and granted its ex-post facto approval for the already procured 40,000 vials.
The ARV is an essential life-saving vaccine, administered to dog bite cases to prevent the deadly rabies infection.
"Currently, there is an acute shortage of this vaccine in Delhi hospitals, since the Central Procurement Agency could not procure due to the withdrawal of rate contract by the bidder, poor availability of ARV in the open market, and single bid participation in the CPA open tender," it added.
The government said that to tackle the situation, a meeting under the chairmanship of DGHS, Government of India, was held at Nirman Bhawan to find out the solution.
In the meeting, various decisions were taken to tackle the situation. It was decided all organisations shall make all the possible effort to overcome the shortage and if required, this vaccine may be procured from the public sector undertaking and other State Medical Service Corporations.
Meanwhile, considering the grim situation, the Finance Department also accorded approval to purchase 30,000 vials from a particular single source, since the availability of this vaccine in the local market is also very scarce.
"During the current financial year 2019-20, there is a Budget provision of Rs 297.80 crore under CPA for the purchase of medicines," stated the press release.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
